Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Dendritic Cell Vaccine
Therapeutic Area : Oncology
Study Phase : IND Enabling
Sponsor : Renovaro Biosciences
Deal Size : Undisclosed
Deal Type : Merger
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine
Details : The combined company aims to accelerate precision, personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms to accelerate Renovaro’s development of potential new therapies, including RENB-DC-11, a dendritic cel...
Product Name : RENB-DC-11
Product Type : Vaccine
Upfront Cash : Undisclosed
September 29, 2023
Lead Product(s) : Dendritic Cell Vaccine
Therapeutic Area : Oncology
Highest Development Status : IND Enabling
Sponsor : Renovaro Biosciences
Deal Size : Undisclosed
Deal Type : Merger